Felix Steiner is a leading expert at the intersection of biotechnology and space research, specializing in microgravity-enabled life sciences and commercial space applications. As Head of Business Development at Yuri, he plays a pivotal role in advancing the commercialization of space-based biotech solutions, working closely with pharmaceutical, life sciences, and biomanufacturing industries to unlock the potential of space for drug discovery, regenerative medicine, and biomaterials development. With a background in aerospace engineering and strategic business development, Felix has been instrumental in establishing international partnerships with space agencies such as ESA, NASA, and DLR, as well as leading global pharma and biotech companies. His expertise includes developing scalable research and production platforms in microgravity, such as ScienceTaxi, enabling innovative organoid research, protein crystallization, and advanced biomaterial fabrication in space. Felix is actively shaping the post-ISS era, ensuring continued reliable access to low Earth orbit for biotech R&D and production. His work contributes to the evolution of space as a key enabler for the next generation of pharmaceutical and medical advancements, making him a sought-after speaker and advisor in the field of space-based biotechnology and commercial space research.